Back to Trials
NCT06770049NARecruiting

Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial

Mayo Clinic

Start Date

1/22/2025

Completion Date

12/1/2030

Summary

The purpose of this study is to develop an evidence-based precision medicine approach for obesity that enhances weight loss and promotes weight loss maintenance.

Eligibility Criteria

Age Range: 18 years to 65 years

Inclusion: • men or women between 18 to 65 years with obesity (BMI\>30kg/m2). Exclusion: * weight change greater than 3% in the previous 3 months * history of bariatric surgery and bariatric endoscopy * untreated psychiatric disorders including binge eating disorders and bulimia * current use of AOMs * history of use of medications affecting weight or energy intake or energy expenditure in the last 6 months * history of type 1 diabetes mellitus or uncontrolled medical conditions (e.g., uncontrolled hypertension) * women who are pregnant or plan to become pregnant, * any condition that limits their participation in the study * Principal Investigator discretion

Interventions

BEHAVIORAL

Standard Lifestyle Intervention (SLI) program

BEHAVIORAL

Phenotype-tailored Lifestyle Intervention (PLI) program

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Obesity

Locations

Mayo Clinic

Rochester, Minnesota 55905

United States